PTSD Trial, Recruiting NCT07175025 Sponsor: Indiana University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT07175025
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You are able to read and speak English
  • You have been assessed as likely having PTSD based on a standard checklist (called the PCL-5)
  • You are currently pregnant, or you have given birth within the last 12 weeks

Who may not be able to join:

  • You are currently considered to be at serious risk of suicide, based on a standard screening tool
  • You are currently experiencing symptoms of psychosis (such as hallucinations or delusions) or mania, as identified by screening questionnaires
  • You have a significant cognitive impairment (difficulties with thinking, memory, or understanding)
  • You are currently receiving therapy that focuses specifically on processing trauma
  • A doctor has advised you not to participate in a type of therapy called exposure therapy (confirm with trial site)
  • You currently have an ongoing legal case related to your trauma
  • You do not meet the criteria for a PTSD diagnosis
  • You are not pregnant, or you gave birth more than 12 weeks before the eligibility screening

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michelle L. Miller, PhD, Indiana University

Phone: 317-963-7257

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 September 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility Tracking; Acceptability; Perinatal NET Protocol Acceptability Questionnaire (PNPAQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov